BESSEMER GROUP INC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
BESSEMER GROUP INC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$8
+100.0%
88
+109.5%
0.00%
Q2 2023$4420.00%
Q4 2022$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q2 2020$4,012,000
-10.1%
44,8000.0%0.01%
-27.8%
Q1 2020$4,465,000
-9.8%
44,800
+3.9%
0.02%
+12.5%
Q4 2019$4,952,000
-8.3%
43,100
+0.7%
0.02%
-15.8%
Q3 2019$5,399,000
+7.1%
42,800
+2.1%
0.02%
+11.8%
Q2 2019$5,042,000
+65.1%
41,900
+20.1%
0.02%
+41.7%
Q1 2019$3,053,000
-10.0%
34,900
+2.9%
0.01%
-20.0%
Q4 2018$3,392,000
+5.0%
33,900
+20.2%
0.02%
+25.0%
Q3 2018$3,231,000
+25.1%
28,200
-2.1%
0.01%
+20.0%
Q2 2018$2,583,000
+12.8%
28,800
-8.0%
0.01%
+11.1%
Q1 2018$2,290,000
+3.8%
31,300
-17.6%
0.01%0.0%
Q4 2017$2,207,000
-16.2%
38,000
-35.3%
0.01%
-18.2%
Q3 2017$2,634,000
+15.0%
58,700
+1.2%
0.01%
+22.2%
Q2 2017$2,290,000
-2.0%
58,000
+0.7%
0.01%
-10.0%
Q1 2017$2,337,000
+0.9%
57,6000.0%0.01%
-9.1%
Q4 2016$2,316,000
+16.9%
57,600
+5.3%
0.01%
+10.0%
Q3 2016$1,981,000
+98950.0%
54,700
+118813.0%
0.01%
Q1 2016$2,000
+100.0%
46
+17.9%
0.00%
Q2 2014$1,000
-75.0%
39
-57.6%
0.00%
Q4 2013$4,000920.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders